首页|增强型体外反搏对冠心病患者炎症因子IL-1、TNF-α和IL-6水平的影响

增强型体外反搏对冠心病患者炎症因子IL-1、TNF-α和IL-6水平的影响

扫码查看
目的 分析增强型体外反搏对冠心病患者炎症因子白细胞介素(IL)-1、肿瘤坏死因子-α(TNF-α)和IL-6水平的影响.方法 选取40例冠心病患者,随机分为研究组和对照组,各20例.对照组接受常规治疗,研究组在常规治疗基础上给予增强型体外反搏治疗.比较两组治疗效果及IL-1、TNF-α、IL-6 水平.结果 治疗后,研究组的心绞痛缓解占比 85.0%、运动耐量增加占比 75.0%、心绞痛缓解且运动耐量增加占比 50.0%明显高于对照组的 50.0%、35.0%、15.0%(P<0.05).对照组治疗后血清IL-1、IL-6 及TNF-α与治疗前比较,无显著差异(P>0.05).研究组治疗后IL-1、IL-6 和TNF-α分别为(6.08±0.53)、(4.61±0.33)、(185.62±10.03)pg/ml,显著低于治疗前的(13.51±0.94)、(6.91±0.26)、(269.41±11.98)pg/ml及对照组治疗后的(12.61±1.17)、(6.17±1.54)、(264.24±12.22)pg/ml(P<0.05).结论 增强型体外反搏治疗冠心病可使患者血清炎症因子表达下降,对抑制炎症反应、减轻心肌缺血具有很好的帮助,值得推广.
Effect of enhanced external counterpulsation on levels of inflammatory cytokines IL-1,TNF-α and IL-6 in patients with coronary heart disease
Objective To analyze the effect of enhanced external counterpulsation on levels of inflammatory cytokines interleukin(IL)-1,tumor necrosis factor-α(TNF-α)and IL-6 in patients with coronary heart disease.Methods 40 patients with coronary heart disease were randomly divided into a study group and a control group,with 20 patients in each group.The control group received conventional treatment,and the study group received enhanced external counterpulsation on the basis of conventional treatment.The therapeutic effect and levels of IL-1,TNF-α and IL-6 were compared between the two groups.Results After treatment,the percentage of remission of angina pectoris of the study group was 85.0%,the percentage of increased exercise tolerance was 75.0%,the percentage of remission of angina pectoris and increased exercise tolerance was 50.0%,which were significantly higher than 50.0%,35.0%and 15.0%of the control group(P<0.05).In the control group,there were no significant differences in serum IL-1,IL-6 and TNF-α before and after treatment(P>0.05).After treatment,the levels of IL-1,IL-6 and TNF-α were(6.08±0.53),(4.61±0.33)and(185.62±10.03)pg/ml in the study group,which were significantly lower than(13.51±0.94),(6.91±0.26)and(269.41±11.98)pg/ml before treatment in this group,and(12.61±1.17),(6.17±1.54)and(264.24±12.22)pg/ml after treatment in the control group(P<0.05).Conclusion Enhanced extracorporeal counterpulsation can reduce the expression of serum inflammatory factors in patients with coronary heart disease,which is helpful in inhibiting inflammatory response and alleviating myocardial ischemia,and is worth popularizing.

Enhanced external counterpulsationCoronary heart diseaseInterleukin-1Interleukin-6Tumor necrosis factor-α

罗超

展开 >

114000 鞍钢集团公司总医院心内科

增强型体外反搏 冠心病 白细胞介素-1 白细胞介素-6 肿瘤坏死因子-α

2024

中国实用医药
中国康复医学会

中国实用医药

影响因子:0.797
ISSN:1673-7555
年,卷(期):2024.19(19)